Form C-AR - Annual Report:
SEC Accession No. 0001670254-25-000415
Filing Date
2025-04-24
Accepted
2025-04-24 16:11:37
Documents
10
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3681
2 document_1.pdf EX-99 8074101
3 document_2.pdf EX-99 8185015
4 document_3.pdf EX-99 8167854
5 document_4.pdf EX-99 1955910
6 document_5.pdf EX-99 1957631
7 document_6.pdf EX-99 11186454
8 document_7.pdf EX-99 1173792
9 document_8.pdf EX-99 4855070
10 documents_list.htm EX-99 123
  Complete submission text file 0001670254-25-000415.txt   60369896
Mailing Address 223 WALL STREET, #130 HUNTINGTON NY 11743
Business Address 223 WALL STREET, #130 HUNTINGTON NY 11743 201-400-8083
SEN-JAM PHARMACEUTICAL INC. (Filer) CIK: 0001802249 (see all company filings)

EIN.: 822750291 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-29297 | Film No.: 25867441